$CVS · CVS HEALTH Corp SEC Filings
Position Tracker tracks 3 SEC EDGAR filings for CVS HEALTH Corp ($CVS) from November 4, 2026 through November 4, 2026, including 0 Form 10-K annual reports, 1 Form 10-Q quarterly earnings reports, 2 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
$CVS 10-Q — CVS HEALTH Corp
CVS's return to profitability is largely a base-effect story from a non-recurring goodwill impairment, but the near-doubling of operating cash flow signals genuine operational i…
$CVS 8-K — CVS HEALTH Corp
CVS delivered a clean beat-and-raise quarter, swinging from a prior-year loss and lifting full-year EPS and cash flow guidance on a recovering Health Care Benefits segment.
$CVS 8-K — CVS HEALTH Corp
A $116.9B healthcare giant unwinding its vertical integration into two focused public companies is a major strategic reset for investors.